Noctera & Revaree Plus
Two women's health products, one brand, two very different jobs: put a menopausal woman to sleep at night, and get her back into her body during the day. Both needed an angle that felt like a diagnosis, not a pitch.
Spec project — created as a portfolio case study, not live client work.
Noctera
Menopause sleep support supplement
Static ad — editorial angle
Static ad — branded
View VSL ad copy
View full VSL script
View additional ad copy variation
The strategy behind it
The research on this market made one thing immediately clear: the real pain is not falling asleep. It is waking up at 3am with a brain that will not stop, lying there for two hours, and doing it again the next night. Every competitor in this category leads with "helps you fall asleep." That framing misses where the actual suffering lives.
The angle I built this funnel around was the GABA gap. When estrogen drops during menopause, it disrupts the GABA and glutamate signals that keep the brain quiet at night. Melatonin works on circadian rhythm, a completely different pathway. That is why melatonin never fully solved it. This is a mechanism-first market, and that mechanism is the most specific and underexplained story in the entire category.
Leading with "this is not a melatonin problem" works on two levels. It immediately validates the avatar's experience of failing with melatonin, and it opens the door to a genuinely fresh mechanism she has not heard before. That combination is the fastest path through skepticism for a buyer who has been burned multiple times.
The UGC format was the right vehicle here because this avatar trusts other women who have been through the same experience more than she trusts brand messaging. The VSL was written to sound like a woman sharing something she wishes she had found sooner, not a brand selling a product. The ad copy extended that same voice across two angles: a short punchy version leading with the failed solutions stack, and a long-form "pharmacy nightstand" testimonial that walks through the full emotional arc of a year of broken sleep and what finally changed it.
The clinical trial data was embedded into both the VSL and the ad copy as proof, not decoration. 127 women, double-blind, placebo-controlled, 88% into normal range in 3 weeks. That level of specificity is what separates Noctera from every other supplement in this space and it needed to be treated as the conversion anchor, not a footnote.
Revaree Plus
Vaginal health & comfort supplement
Static ad — editorial angle
Static ad — branded
View VSL ad copy
View full VSL script
View static ad copy — branded
View static ad copy — editorial
The strategy behind it
Revaree Plus presented a creative challenge that went beyond positioning. Vaginal dryness is the symptom menopausal women are least likely to seek help for, because most have been told it is normal, nothing serious, just use more lubricant. That combination of dismissal and embarrassment means the ad has to do two things at once: make the woman feel seen before it makes any claim about the product.
The angle I built this funnel around was the surface vs. tissue distinction. Lubricants treat the surface. Revaree Plus works at the tissue level. That reframe is the mechanism story, and it is the only explanation that makes sense of why everything she has tried only helped temporarily. When estrogen drops, vaginal tissue physically changes. It thins, loses collagen, and stops holding moisture on its own. No amount of surface lubrication changes that. Hyaluronic acid, delivered directly into the tissue, does.
The Gynecologist VSL was the only viable format for the opening. A physician framing removes the embarrassment barrier from the conversation by making it clinical rather than personal. It also gives the mechanism story the credibility it needs to land, especially for a woman who has already been dismissed by her own doctor. The hook was built around a progression most women in this avatar will recognize: dryness to discomfort to pain during intimacy to quietly withdrawing from it altogether.
That arc mirrors what actually happens, and naming it out loud is what stops the scroll. The long-form ad copy took a different approach. Written in a first-person UGC voice, it followed a woman through three doctors, two years of lubricants, and a marriage quietly absorbing the impact of a problem nobody had a real answer for. That format works because it mirrors the exact journey this avatar has been on, with enough specificity in the detail (the wince her husband noticed, the girls' trips she started skipping) to feel like a real account rather than a brand story.
The listicle lander was built to bridge the emotional hook of the ads into the clinical proof and practical specifics the buyer needs before committing. Timeline, mechanism, usage routine, and social proof were structured to answer the questions this skeptical buyer brings to every supplement she considers.
Brand brief — Bonafide
About the brand
Bonafide is a women's health supplement company built around one premise: women deserve science-backed solutions for what their bodies actually go through, not generic wellness products with the packaging swapped out. The product line targets perimenopause and menopause specifically, with formulations developed alongside OB/GYNs and backed by clinical trial data. It sits in a precise middle ground between pharmaceutical credibility and supplement accessibility — hormone-free, clinically studied, and trusted by more than 1.3 million women and recommended by more than 13,000 doctors.
Target market
Their customer has been dismissed by at least one doctor. She has spent money on things that didn't work. She is educated, skeptical, and done accepting that feeling terrible is just part of getting older. She needs a reason to believe before she buys, and she responds to specificity over promises.
Noctera
Product: Noctera, a melatonin-free, hormone-free sleep supplement formulated specifically for menopausal sleep disruption. Backed by a double-blind, placebo-controlled clinical trial of 127 women showing 88% moved from moderate-to-severe sleep disruption into normal range within 3 weeks.
Avatar: Women 45–58 in perimenopause or menopause who wake up at 2 or 3am and cannot fall back asleep. They have already tried melatonin, magnesium, herbal blends, and possibly prescription sleep aids. Nothing has worked. They are not looking for another sleep supplement. They are looking for a reason to believe this one is different.
Funnel stage: Cold traffic, Meta in-feed.
Assets produced: UGC VSL script, 2 Facebook ad copy variations, fully designed lander, static image ads.
Revaree Plus
Product: Revaree Plus, a hormone-free vaginal insert using hyaluronic acid to restore moisture at the tissue level. Clinically studied, recommended by 13,000+ doctors, 4.6 stars across 1,000+ reviews.
Avatar: Women 45–60 in perimenopause or menopause experiencing vaginal dryness, discomfort during intimacy, and a quiet withdrawal from physical connection with their partner. They have cycled through lubricants and moisturizers. Nothing has provided lasting relief. Many have seen multiple doctors and received answers that felt dismissive or incomplete. They have stopped bringing it up.
Funnel stage: Cold traffic, Meta in-feed.
Assets produced: Gynecologist VSL script, 2 Facebook ad copy variations, fully-designed listicle lander, static image ads.